NCT00740207View on ClinicalTrials.gov

Pilot Study to Compare ISOVUE®-250 and VISIPAQUE™ 270 for Motion Artifact and Pain in Peripheral DSA

PHASE4CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

July 31, 2009

Study Completion Date

July 31, 2009

Conditions
Peripheral Arterial Occlusive Disease
Interventions
DRUG

VISIPAQUE 270

VISIPAQUE 270 (Iodixanol Injection) is provided in bottles/flexible containers, ready to use sterile, pyrogen-free colorless to pale yellow solution

DRUG

Isovue 250

ISOVUE-250 (Iopamidol Injection) is provided in single dose bottles/vials, ready to use, aqueous, nonpyrogenic, colorless to pale yellow sterile solution

Sponsors
All Listed Sponsors
lead

Bracco Diagnostics, Inc

INDUSTRY